Clearmind Medicine Inc. (CMND)
NASDAQ: CMND · Real-Time Price · USD
1.200
+0.010 (0.84%)
Dec 20, 2024, 4:00 PM EST - Market closed
Clearmind Medicine Balance Sheet
Financials in millions USD. Fiscal year is November - October.
Millions USD. Fiscal year is Nov - Oct.
Fiscal Year | TTM | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | 2018 - 2017 |
|---|---|---|---|---|---|---|---|
Period Ending | Jul '24 Jul 31, 2024 | Oct '23 Oct 31, 2023 | Oct '22 Oct 31, 2022 | Oct '21 Oct 31, 2021 | Oct '20 Oct 31, 2020 | Oct '19 Oct 31, 2019 | 2018 - 2017 |
| Cash & Equivalents | 7.68 | 5.43 | 0.13 | 4.6 | 0.33 | 0 | Upgrade
|
| Short-Term Investments | - | 0.09 | 0.19 | - | - | - | Upgrade
|
| Cash & Short-Term Investments | 7.68 | 5.51 | 0.32 | 4.6 | 0.33 | 0 | Upgrade
|
| Cash Growth | 93.44% | 1609.58% | -92.99% | 1294.44% | 47842.01% | -99.07% | Upgrade
|
| Other Receivables | 0.19 | 0.24 | 0.1 | 0.16 | 0 | 0 | Upgrade
|
| Receivables | 0.19 | 0.24 | 0.1 | 0.16 | 0 | 0 | Upgrade
|
| Prepaid Expenses | 0.12 | 0.04 | 0.01 | 0.16 | - | - | Upgrade
|
| Total Current Assets | 7.99 | 5.79 | 0.43 | 4.92 | 0.33 | 0 | Upgrade
|
| Property, Plant & Equipment | 0.06 | 0 | 0.05 | 0.02 | - | 0.17 | Upgrade
|
| Other Intangible Assets | 0.11 | 0.12 | 0.13 | 0.2 | - | - | Upgrade
|
| Long-Term Deferred Charges | - | - | 0.2 | - | - | - | Upgrade
|
| Other Long-Term Assets | 0.01 | 0.04 | 0.01 | 0.02 | - | - | Upgrade
|
| Total Assets | 8.17 | 5.95 | 0.83 | 5.16 | 0.33 | 0.18 | Upgrade
|
| Accounts Payable | 0.28 | 0.62 | 1.4 | 0.35 | 0.01 | 0.01 | Upgrade
|
| Accrued Expenses | 0.05 | 0.04 | 0.21 | 0.01 | 0.01 | 0.03 | Upgrade
|
| Current Portion of Leases | 0.04 | - | 0.04 | - | - | - | Upgrade
|
| Other Current Liabilities | 4.31 | 4.31 | 0.29 | - | - | - | Upgrade
|
| Total Current Liabilities | 4.67 | 4.97 | 1.93 | 0.36 | 0.01 | 0.04 | Upgrade
|
| Total Liabilities | 4.7 | 4.97 | 1.93 | 0.36 | 0.01 | 0.04 | Upgrade
|
| Common Stock | 23.8 | 17.13 | 6.71 | 7.91 | 0.89 | 0.29 | Upgrade
|
| Retained Earnings | -23.14 | -18.77 | -10.15 | -4.44 | -0.72 | -0.31 | Upgrade
|
| Comprehensive Income & Other | 2.81 | 2.62 | 2.33 | 1.34 | 0.15 | 0.15 | Upgrade
|
| Shareholders' Equity | 3.47 | 0.98 | -1.11 | 4.8 | 0.32 | 0.13 | Upgrade
|
| Total Liabilities & Equity | 8.17 | 5.95 | 0.83 | 5.16 | 0.33 | 0.18 | Upgrade
|
| Total Debt | 0.06 | - | 0.04 | - | - | - | Upgrade
|
| Net Cash (Debt) | 7.62 | 5.51 | 0.28 | 4.6 | 0.33 | 0 | Upgrade
|
| Net Cash Growth | 91.91% | 1840.56% | -93.82% | 1294.44% | 47842.01% | -99.07% | Upgrade
|
| Net Cash Per Share | 3.51 | 27.23 | 6.56 | 148.80 | 18.19 | 0.06 | Upgrade
|
| Filing Date Shares Outstanding | 4.06 | 3.17 | 0.04 | 0.04 | 0.02 | 0.01 | Upgrade
|
| Total Common Shares Outstanding | 3.98 | 0.61 | 0.04 | 0.04 | 0.02 | 0.01 | Upgrade
|
| Working Capital | 3.32 | 0.82 | -1.5 | 4.56 | 0.32 | -0.04 | Upgrade
|
| Book Value Per Share | 0.87 | 1.62 | -25.14 | 115.17 | 14.96 | 10.85 | Upgrade
|
| Tangible Book Value | 3.36 | 0.86 | -1.24 | 4.6 | 0.32 | 0.13 | Upgrade
|
| Tangible Book Value Per Share | 0.84 | 1.42 | -28.10 | 110.42 | 14.96 | 10.85 | Upgrade
|
| Machinery | - | - | - | 0.02 | - | - | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.